An antibody from single human V <sub>H</sub> -rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion
Sai Luo(Boston Children's Hospital), Frederick W. Alt(Boston Children's Hospital), Kenneth Cronin(Duke Medical Center), S. Munir Alam(Duke University), Hanqin Peng(Boston Children's Hospital), Maggie Barr, Novalia Pishesha(Broad Institute), Amanda Eaton(Duke Medical Center), Adam Yongxin Ye(Harvard University), Alex J.B. Kreutzberger(University of Virginia), Barton F. Haynes(Duke University), Changbin Jing(Boston Children's Hospital), Tomas Kirchhausen(Boston Children's Hospital), Lorenza Bellusci(Center for Biologics Evaluation and Research), Katayoun Mansouri(Duke University), Ming Tian(Boston Children's Hospital), Surender Khurana(Center for Biologics Evaluation and Research), Anand Saminathan(Boston Children's Hospital), Kevin O. Saunders(Duke University), Hidde L. Ploegh(Boston Children's Hospital), Himanshu Batra(Boston Children's Hospital), Robert Parks(Duke University), Hai‐Qiang Dai(Boston Children's Hospital), Aimee Williams(Boston Children's Hospital), Lucas Vieira Francisco(Boston Children's Hospital), Gregory D. Sempowski(Duke University), Bing Chen(Xinjiang Academy of Agricultural and Reclamation Science), David C. Montefiori(Duke University), Robert J. Edwards(Duke University), Jun Zhang(Harvard University)
Cited by 60
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Distinct conformational states of SARS-CoV-2 spike protein
|Science|2020|1.4k